| Yap, Richard (Numares 201612– Managing Director of Numares Singapore before Avdisor + OrbusNeich) |
Managing Director |
Numares (Group) |
Singapore |
| Yaspo, Marie-Laure |
n. a. |
Source BioScience (Group) |
Germany |
| Yates, Robert (Merck (DE) 201109–201493 President of Merck Millipore before Roche Diagnostics LEFT 3/14) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Yeager, Frank (Eckert & Ziegler 202305– promoted to Management Board Director for Isotope Products) |
Board member, executive |
Eckert & Ziegler (Group) |
Germany |
| Yee, Sidney (Singapore (govt) 201510 CEO of DxD Hub of A*STAR) |
Chief Executive Officer (CEO) |
Singapore (govt) |
Singapore |
| Yemm, Stephen (Steve) (Optibrium 202301– Chief Commercial Officer before Paradigm4 + Aigenpulse + BioData + Vialis) |
Chief Commercial Officer (CCO) |
Optibrium (Group) |
United Kingdom (GB) |
| Yerganian, Syrane (Strammer 201704 CFO) |
Chief Executive Officer (CEO) |
Strammer (Group) |
France |
| Yianni, John (CryoTherapeutics GmbH 201305 Managing Director) |
Managing Director |
CryoTherapeutics GmbH |
Germany |
| Yildiz, Marius (Murat) (Avergen Pharmaceuticals GmbH 201510– Managing Director) |
Managing Director |
Avergen Pharmaceuticals GmbH (APG) |
Germany |
| Ylisaukko-oja, Tero (MedEngine Oy 201901 CEO) |
Chief Executive Officer (CEO) |
|
|
| Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) |
Chief Executive Officer (CEO) |
Pieris (Group) |
Germany |
| Yoo, Stephen (Anjarium Biosciences 202206– CEO before Third Harmonic Bio + Regenxbio + MedImmune + Abbott Labs) |
Chief Executive Officer (CEO) |
Anjarium Biosciences AG |
Switzerland |
| York, Gwill (Lighthouse Capital Partners 202110 Founding Managing Director) |
Managing Director |
Lighthouse Capital Partners (US) |
United States (USA) |
| Yoshitaka, Shinsuke (Denka 201508 President + CEO) |
Chief Executive Officer (CEO) |
Denka (Group) |
Japan |
| Young, Diane (Novartis Oncology 200601) |
n. a. |
Novartis (Group) |
Switzerland |
| Young, Jordan (Repare Therapeutics 202305 Director of SNIPRx platform) |
n. a. |
|
|
| Young, Joshua (Bruker 201301– VP Investor Relations before Merck KGA + Millipore LEFT BEFORE 7/16) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
| Yousaf, Shaf (Sigma-Aldrich 201412 VP Tech + BusDev before Life Technologies + Applied Biosystems + Sigma-Aldrich) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Yrjänheikki, Juha (Aurealis Pharma 201708 CEO) |
Chief Executive Officer (CEO) |
Aurealis Therapeutics AG |
Switzerland |
| Yu, Chen (TCG Crossover 202107 Managing Partner + Founder before Vivo Capital 201504 Managing Partner) |
Managing Partner (investment firm) |
Column Group LLC, The (TCG) |
United States (USA) |
| Yu, Frank (Ally Bridge Group 201702 CEO + CIO + Founder) |
Chief Executive Officer (CEO) |
Ally Bridge Group (ABG) |
China |
| Yu, Guo-Liang (Epitomics 201105 CEO) |
Chief Executive Officer (CEO) |
Abcam (Group) |
United States (USA) |
| Yule, Murray (iOmx Therapeutics 202202– CMO before MorphoSys) |
Chief Medical Officer (CMO) |
iOmx Therapeutics AG |
Germany |
| Yusibov, Vidadi (Fraunhofer USA 201009 Exec Director CMB + iBio 201009 CSO) |
Researcher (university / research institute) |
Fraunhofer (Group) |
United States (USA) |
| Yver, Antoine (AstraZeneca 201309 VP + Head of Oncology in Global Medicines Development Unit) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
| Yzer, Cornelia (Berlin (govt) 201305 Senator of Economy, Technology, and Research) |
Minister |
Berlin (govt region) |
Germany |
| Yönel, Mutlu (Prosion 202308 Managing Director (CFO) + Co-Founder) |
Chief Financial Officer (CFO) |
Prosion GmbH (Prosion Therapeutics) |
Germany |
| Zabel, Nina (BioRegio STERN 201802–) |
Cluster Manager |
BioRegio STERN Management GmbH |
Germany |
| Zabrowski, Dan (Roche 201202– Head Roche Applied Science before Roche Global Head Pharma Partnering) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Zaby, Andreas (Curacyte 200601) |
n. a. |
Curacyte (Group) |
Germany |
| Zacharias, Dietmar (Hochschule Bremen 201303 Professor for Applied + Ecological Botanics) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
| Zachert, Matthias (Lanxess 201401– CEO before Merck (DE) CFO) |
Chief Executive Officer (CEO) |
Lanxess (Group) |
Germany |
| Zachmann, Julian (Strüngmann Group 202308 Investment Manager before HTGF) |
Investment Manager |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Zafirakos, Elias (BioPeople (DK) 201404 Science Liaison Officer) |
Cluster Manager |
Biopeople (Denmark’s Life Science Cluster) |
Denmark |
| Zahn, Dorothea (BST Bio Sensor Technology GmbH 201110 Managing Director) |
Managing Director |
BST Bio Sensor Technologie GmbH |
Germany |
| Zahn, Grit (Eternygen GmbH 201309– Head of Research before ipal GmbH + Jerini) |
Research & Development Manager |
Eternygen (Group) |
Germany |
| Zahn, Ralph (Priavoid 201709– Co-Founder formerly Biocrates 201306 CTO) |
Chief Technology/Technical Officer (CTO) |
Priavoid GmbH |
Germany |
| Zahnd, Christian (Molecular Partners 200708 CEO RESIGNED 11/16) |
Chief Executive Officer (CEO) |
Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) |
Switzerland |
| Zaimenko, Inna (Versatile Biology Lab 202210 Founder) |
Company Founder |
Versatile Biology Lab (Inna Zaimenko) |
Germany |
| Zambon, Elena (Zambon 201907 President) |
Board member |
Zambon (Group) |
Italy |
| Zamboni, Nicola (ETH Zurich 201007 Institute of Molecular Systems Biology) |
Researcher (university / research institute) |
ETH Zürich (ETHZ) |
Switzerland |
| Zampieri, Gianni (Galenica Group 201702 CEO of Vifor Pharma) |
Chief Executive Officer (CEO) |
Vifor Pharma (Group) |
Switzerland |
| Zanchi, Marta-Gaia (Nina Capital 202011 Founder + Managing Partner) |
Partner (venture partner) |
Nina Capital SGEIC S.A. |
Spain (España) |
| Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
| Zanzinger, Johannnes (Boehringer 202001 at BIVF) |
Investment Manager |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Zapico, David A. (AMETEK 201608 CEO) |
Chief Executive Officer (CEO) |
AMETEK (Group) |
United States (USA) |
| Zarrehparvar, Mazi (MicrobeDx 201701 CEO) |
Chief Executive Officer (CEO) |
MicrobeDx (Group) |
United States (USA) |
| Zauderer, Maurice (Vaccinex 200803 CEO) |
Chief Executive Officer (CEO) |
Vaccinex Inc. |
United States (USA) |
| Zazulina, Victoria (Merck (DE) 202209 Head of Development Unit Oncology before Boehringer Ingelheim) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Zbar, Brett (General Atlantic 202009– Managing Director + Global Head Life Sciences before Foresite Capital + Aisling) |
Managing Director |
General Atlantic (Group) |
United States (USA) |
| Zbinden, Laurent (MedXCell 202203 CEO) |
Chief Executive Officer (CEO) |
MedXCell (Group) |
Switzerland |
| Zech, Birgit (Anavo Therapeutics 202104 CEO before Gotham Therapeutics + X-Rx + MAB Discovery + Pieris + Axxima) |
Chief Executive Officer (CEO) |
Anavo Therapeutics (Group) |
Netherlands |
| Zechner, Rudolf (Univ Graz 201308 Professor at Instittue for Molecular Biosciences) |
Professor |
University of Graz (Karl-Franzens-Universität) |
Austria |
| Zeh, Alexander (Tacalyx 202205 Head of Finance + Administration) |
Chief Financial Officer (CFO) |
Tacalyx GmbH |
Germany |
| Zehethofer, Karl |
n. a. |
Greiner (Group) |
Austria |
| Zehetmayer, Peter (Acquifer Imaging 202301 COO + Director for Sales + Marketing) |
Chief Operating Officer (COO) |
Bruker (Group) |
Germany |
| Zehnder, Alexander (CureVac 202304– CEO before Sanofi + Roche/Genetech) |
Chief Executive Officer (CEO) |
CureVac (Group) |
Germany |
| Zehntner, Heiner (Endress+Hauser 201309 Member of Executive Board) |
Board member, executive |
Endress+Hauser (Group) |
Switzerland |
| Zeidler, Reinhard (Helmholtz 201801 Prof Gene Vectors Research Unit at Helmholtz Zentrum München) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Zeinali, Sirous (Genetek Biopharma 201805 Managing Director + Co-Founder) |
Managing Director |
Genetek Biopharma GmbH |
Germany |
| Zeise, Antje (Epigenomics 201112 Manager IR | PR) |
Public Relations Manager / Investor Relations Manager |
Epigenomics (Group) |
Germany |
| Zell, Andreas |
n. a. |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Zeller, Marco (VC Fonds Berlin 200508 Managing Director) |
Managing Director |
Berlin (govt region) |
Germany |
| Zeltner, Jürg (UBS 201604 President of UBS Wealth Management) |
President/Director/Head Business Group/Unit/Division |
UBS (Group) |
Switzerland |
| Zeltz, Patric (BadenBioTec 201104 Managing Director before BF-Biolabs 200312– founder) |
Managing Director |
BadenBioTec GmbH |
Germany |
| Zencke, Peter (MeVis Medical Solutions 200708–201106 Supervisory Board Member) |
Supervisory Board Member |
Varian Medical Systems (Group) |
Germany |
| Zenker, Matthias (GAIA 201702 Business Development) |
Business Development Manager / Strategy Manager |
GAIA AG |
Germany |
| Zenker, Othmar (InflaRx 201706– CMO before Head Clinical Research + Development since 2013 before CSL Behring) |
Research & Development Manager |
InflaRx (Group) |
Germany |
| Zenobi, Renato (ETH Zürich 201006 Professor Dept of Chemistry) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Zentgraf, Martin (Desitin 201202 General Manager of Desitin Arzneimittel GmbH) |
General Manager (management) |
Desitin Arzneimittel GmbH |
Germany |
| Zepp, Tobias (CRS Clinical Research Services 201706 Corporate Communications Manager) |
Public Relations Manager / Investor Relations Manager |
CRS Clinical Research Services (Group) |
Germany |
| Zerhouni, Elias A. (Sanofi-Aventis 201101– President Global RnD before NIH Director 2002–2008) |
Research & Development Manager |
Sanofi (Group) [since May 2011] |
France |
| Zerrer, Ralf (Clariant 201801 Head Strategic Marketing + Innovation at Business Unit Industrial + Consumer Specialties) |
Sales Manager / Marketing Manager |
Clariant (Group) |
Switzerland |
| Zettl, Rolf (Combinature co-founder + CEO 200011–200504 afterwards CBO) |
Chief Business Officer (CBO) |
MerLion (Group) |
Germany |
| Zettl, Rolf (Helmholtz 201502 Managing Director) |
Managing Director |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Zettl, Sophie (CEBINA 202003 before Arsanis + MedImmune/AZ) |
Business Development Manager / Strategy Manager |
CEBINA GmbH (Central European Biotech Incubator and Accelerator) |
Austria |
| Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) |
Chief Executive Officer (CEO) |
Valneva (Group) |
Austria |
| Zetzmann-Krien, Diane (Bremen (govt) 201110 Managing Director of Bremer Aubau-Bank GmbH) |
Managing Director |
Bremen (govt region) |
Germany |
| Zeyer, Denis (Novalix 201011 CEO) |
Chief Executive Officer (CEO) |
Novalix (Group) |
France |
| Zeyfang, D. |
n. a. |
DaimlerChrylser (Group) |
Germany |
| Zhang, Ingrid (Novartis 201904 President Novartis Pharmaceuticals China) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
China |
| Zhang, Jay Z. (Shuwen Biotech 201512 CEO) |
Chief Executive Officer (CEO) |
Shuwen Biotech Co. Ltd. |
China |
| Zhang, Lei (Univ Bremen 200603) |
n. a. |
University of Bremen |
Germany |
| Zhang, Peizhuo (Qiagen 201305– General Manager of Qiagen (Suzhou) Translational Medical Center) |
General Manager (management) |
Qiagen (Group) |
China |
| Zhang, Weiyi (Boehringer 202007 Head of External Innovation Hub China) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
China |
| Zhang, Zeeman (Beijing Clear Biotech 201509 Director) |
President/Director/Head Business Group/Unit/Division |
Beijing Clear Biotech Co., Ltd. (BCB) |
China |
| Zhao, Xing (ReLive 202301 CEO + Founder) |
Chief Executive Officer (CEO) |
ReLive (Group) |
|
| Zheng, Li-Mou (Amoy Diagnostics 201607 CEO) |
Chief Executive Officer (CEO) |
Amoy Diagnostics Co., Ltd. (AmoyDx) |
China |
| Zhou, Frank (Grand Pharmaceutical 202112 CEO) |
Chief Executive Officer (CEO) |
Grand Pharmaceutical Group Ltd. (Grand Pharma, GP) |
China |
| Zhou, Jack (B&W Tek LLC 201807 CEO) |
Chief Executive Officer (CEO) |
Metrohm (Group) |
United States (USA) |
| Zhou, Li (TxCell 201610– VP Cell Engineerung before ZMKS + Novartis Biologics Center MA + MGH + Cereon Genomics) |
Researcher (industry) |
TxCell S.A. (Euronext Paris: TXCL) |
France |
| Zhou, WeiQing (LifeMine Therapeutics 202102 COO + Co-Founder + FogPharma COO + Co-Founder) |
Chief Operating Officer (COO) |
LifeMine Therapeutics (Group) |
United States (USA) |
| Zhu, John (DualityBio 202304 CEO + Founder formerly 6 Dimensions Capital) |
Chief Executive Officer (CEO) |
|
|
| Zhu, Ted (Fosun Group 201407 General Manager of Fosun Diagnostics division) |
General Manager (management) |
Fosun (Group) |
China |
| Zhukovsky, Eugene (Biomunex 201510– CSO before Affimed + Boehringer Ingelheim Pharmaceuticals + Xencor) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biomunex Pharmaceuticals SASU |
France |
| Zickgraf, Patrik (Ganzimmun Diagnostics 202112 CEO) |
Chief Executive Officer (CEO) |
Ganzimmun Diagnostcs AG (GD) |
Germany |
| Ziebig, Marlene (Gulde Hengelhaupt Ziebig & Schneider 200809 Berlin) |
n. a. |
Grünecker, Kinkeldey, Stockmair & Schwanhäusser GbR |
Germany |
| Ziebolz, Burkhard (Roche Diagnostics 200503) |
n. a. |
Roche (Group) |
Germany |
| Ziegelbauer, Karl (Almirall 202205 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Almirall (Group) |
Spain (España) |
| Ziegenhagen, Andreas (Dentons 201412 Managing Partner Germany) |
Managing Partner |
Dentons (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
